Tuberculosis due to Mycobacterium kansasii.
Eighteen cases of tuberculosis due to Mycobacterium kansasii have been described. Eleven were from Western Australia and seven from Queensland. The symptoms, X-rays and histology of the disease were indistinguishable from those due to Mycobacterium tuberculosis, but the organisms were resistant to streptomycin, para-amino-salicylic (PAS) and isoniazid, but sensitive to ethionamide and cycloserine, and in most cases sensitive to rifampicin and ethambutol. All 18 cases were treated with some form of chemotherapy; three also had surgery.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000382:microbiology; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery
D000995:Antitubercular Agents